SCYNEXIS Inc —— 资产负债表 (NASDAQ:SCYX)

Financials

总资产 102.54 M119.84 M87.81 M128.41 M90.64 M59.03 M 负债总额 79.78 M78.58 M84.58 M55.45 M35.57 M9.65 M 权益总额 22.76 M41.26 M3.23 M72.96 M55.08 M49.38 M 负债及股东权益总额 102.54 M119.84 M87.81 M128.41 M90.64 M59.03 M 总债务 —28.75 M34.39 M0—— 净债务 —-75.74 M-39.11 M-98 M——

新闻

SCYNEXIS, Inc. (SCYX) Discusses Transformative Asset Acquisition and Strategic Shift Toward ADPKD Therapeutics - Slideshow (NASDAQ:SCYX) 2026-04-01

Brookline Capital下调SCYNEXIS目标价，基于估值考量

Brookline Capital cuts SCYNEXIS stock price target on valuation

SCYNEXIsQ1每股收益及营收超出预期

Scynexis Inc earnings beat by $0.12, revenue topped estimates

SCYNEXIS在SCY-247静脉注射制剂试验中完成首批患者给药

SCYNEXIS doses first patients in SCY-247 IV formulation trial

JERSEY CITY - FDA grants fast track and QIDP designations to SCYNEXIS drug

Scynexis获得纳斯达克180天延期以满足上市要求

Scynexis receives 180-day extension from Nasdaq to meet listing requirements

SCYNEXIS获得700万美元年度拨款用于抗真菌研究

SCYNEXIS receives $7 million annual grant for antifungal research